Physician

Emile Chawki Salloum, MD

According to 2025 Medicare claims, Emile Salloum, MD (NPI: 1144209024) practices hematology/oncology in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is COASTAL BEND CANCER CENTER, PA (NPI: 1043299415; TIN: 742898314) and primary practice location at 78412-4926. Salloum is affiliated with the Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), participating under the MSSP model.

Salloum's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 319 traditional Medicare patients, billed 202,162 HCPCS/CPT codes, and received $2,966,522 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,827 prescription claims across 454 beneficiaries totaling $7,903,798 in drug costs, led by Cabometyx (Cabozantinib S-Malate). 2023 DME data shows 135 claims. Open Payments data shows 196 records totaling $4,721. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,549,896 to $2,966,522. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,621,796 to $7,903,798. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $10,205 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.5M2015 Medicare payment: $1,549,896 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,560,822 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,793,434 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,115,468 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,201,318 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,790,117 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,496,013 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,195,736 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,469,622 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,966,522 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015449127,512$1,549,896
2016437131,299$1,560,822
2017463127,263$1,793,434
2018424174,324$2,115,468
2019410129,978$2,201,318
2020377145,058$2,790,117
2021384169,329$3,496,013
2022375131,295$3,195,736
2023367185,828$3,469,622
2024319202,162$2,966,522

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.0M$7.9M2015 Drug cost: $1,621,796 (USD; Tot_Drug_Cst)2016 Drug cost: $1,689,909 (USD; Tot_Drug_Cst)2017 Drug cost: $1,862,147 (USD; Tot_Drug_Cst)2018 Drug cost: $1,618,319 (USD; Tot_Drug_Cst)2019 Drug cost: $1,796,743 (USD; Tot_Drug_Cst)2020 Drug cost: $3,460,149 (USD; Tot_Drug_Cst)2021 Drug cost: $5,296,122 (USD; Tot_Drug_Cst)2022 Drug cost: $7,290,012 (USD; Tot_Drug_Cst)2023 Drug cost: $7,659,945 (USD; Tot_Drug_Cst)2024 Drug cost: $7,903,798 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153392,188$1,621,796
20163342,133$1,689,909
20173772,255$1,862,147
20183712,216$1,618,319
20193752,093$1,796,743
20203942,233$3,460,149
20213992,206$5,296,122
20223882,276$7,290,012
20234142,442$7,659,945
20244542,827$7,903,798

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$13K$26K2015 Medicare payment: $9,652 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $19,383 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $6,673 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $119 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,440 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,249 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $25,914 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201530105$9,652
2016N/R108$19,383
2017N/R15$6,673
2018N/R12$119
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R53$3,440
2022N/R88$3,249
2023N/R135$25,914
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less68612$91
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more209436$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more106173$65
96367Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less61837$21
J1100Injection, dexamethasone sodium phosphate, 1 mg565,938$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CabometyxCabozantinib S-Malate421,260$957,149
LenalidomideLenalidomide802,238$945,559
RevlimidLenalidomide391,091$670,958
LenvimaLenvatinib Mesylate27810$656,755
IbrancePalbociclib401,120$578,583

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.196$4,721AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Emile Chawki Salloum, MD?

Tedicare shows public-source Medicare data for Emile Chawki Salloum, MD (NPI 1144209024), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emile Chawki Salloum, MD have ACO affiliation data?

Emile Chawki Salloum, MD is shown with ACO affiliation data for Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400).

What billing organization is linked to Emile Chawki Salloum, MD?

Emile Chawki Salloum, MD is linked to COASTAL BEND CANCER CENTER, PA (billing NPI 1043299415) in the available physician profile data.

Does Emile Chawki Salloum, MD have Open Payments data?

Emile Chawki Salloum, MD has 196 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.